Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Raw Areca Nut Betel Quid Consumption and Esophageal Cancer

Oncotarget

February 22, 2024
In this new study, researchers provide valuable insights into raw areca nut betel quid consumption and esophageal cancer. continue reading »

Combining Causal and Correlative Approaches to Discover Response Biomarkers to Paclitaxel

News

February 21, 2024
PRESS RELEASE: On February 8, 2024, a new research perspective was published in Oncotarget, entitled, “Combining causal and correlative approaches to discover biomarkers of response to paclitaxel.” continue reading »

NTRK Gene Fusion in Papillary Thyroid Cancer: A Clinicogenomic Biobank and Record Linkage Study From Finland

News

February 19, 2024
PRESS RELEASE: On February 5, 2024, a new research paper was published in Oncotarget, entitled, “Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.” continue reading »

Oncotarget’s Top 10 Papers Published in 2023 (Crossref Data)

Oncotarget

February 15, 2024
Read Oncotarget’s Top 10 papers published in 2023 (based on data from Crossref). continue reading »

Genetic and Therapeutic Landscapes in Cohort of Pancreatic Adenocarcinomas Using NGS and Machine Learning

News

February 14, 2024
PRESS RELEASE: On February 5, 2024, a new research paper was published in Oncotarget, entitled, “Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation sequencing and machine learning for full tumor exome analysis.” continue reading »